» Articles » PMID: 24710554

Signals and Cells Involved in Regulating Liver Regeneration

Overview
Journal Cells
Publisher MDPI
Date 2014 Apr 9
PMID 24710554
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Liver regeneration is a complex phenomenon aimed at maintaining a constant liver mass in the event of injury resulting in loss of hepatic parenchyma. Partial hepatectomy is followed by a series of events involving multiple signaling pathways controlled by mitogenic growth factors (HGF, EGF) and their receptors (MET and EGFR). In addition multiple cytokines and other signaling molecules contribute to the orchestration of a signal which drives hepatocytes into DNA synthesis. The other cell types of the liver receive and transmit to hepatocytes complex signals so that, in the end of the regenerative process, complete hepatic tissue is assembled and regeneration is terminated at the proper time and at the right liver size. If hepatocytes fail to participate in this process, the biliary compartment is mobilized to generate populations of progenitor cells which transdifferentiate into hepatocytes and restore liver size.

Citing Articles

SLC13A2 promotes hepatocyte metabolic remodeling and liver regeneration by enhancing de novo cholesterol biosynthesis.

Shi L, Chen H, Zhang Y, An D, Qin M, Yu W EMBO J. 2025; 44(5):1442-1463.

PMID: 39824985 PMC: 11876347. DOI: 10.1038/s44318-025-00362-y.


Myeloid derived suppressor cells mediate hepatocyte proliferation and immune suppression during liver regeneration following resection.

Nachmany I, Nevo S, Edelheit S, Sarusi-Portuguez A, Friedlander G, Salame T Genes Immun. 2024; 25(6):483-491.

PMID: 39488626 DOI: 10.1038/s41435-024-00303-5.


MAD1 deficiency accelerates hepatocellular proliferation via suppressing TGF-β signaling.

Deng J, Teng J, Xiao T, Wen J, Meng W Heliyon. 2024; 10(10):e31312.

PMID: 38813231 PMC: 11133804. DOI: 10.1016/j.heliyon.2024.e31312.


Antagonizing Activin A/p15 Signaling as Therapeutic Strategy for Liver Disease.

Mekala S, Rai R, Reed S, Bowen B, Michalopoulos G, Locker J Cells. 2024; 13(7.

PMID: 38607090 PMC: 11011318. DOI: 10.3390/cells13070649.


A liver digital twin for in silico testing of cellular and inter-cellular mechanisms in regeneration after drug-induced damage.

Zhao J, Ghallab A, Hassan R, Dooley S, Hengstler J, Drasdo D iScience. 2024; 27(2):108077.

PMID: 38371522 PMC: 10869925. DOI: 10.1016/j.isci.2023.108077.


References
1.
Mehendale H . Once initiated, how does toxic tissue injury expand?. Trends Pharmacol Sci. 2012; 33(4):200-6. DOI: 10.1016/j.tips.2012.01.003. View

2.
Schuppan D, Schmid M, Somasundaram R, Ackermann R, Ruehl M, Nakamura T . Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology. 1998; 114(1):139-52. DOI: 10.1016/s0016-5085(98)70642-0. View

3.
Fafalios A, Ma J, Tan X, Stoops J, Luo J, DeFrances M . A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat Med. 2011; 17(12):1577-84. PMC: 3233634. DOI: 10.1038/nm.2531. View

4.
Widmann J, Fahimi H . Proliferation of mononuclear phagocytes (Kupffer cells) and endothelial cells in regenerating rat liver. A light and electron microscopic cytochemical study. Am J Pathol. 1975; 80(3):349-66. PMC: 1913009. View

5.
Webber E, FitzGerald M, Brown P, Bartlett M, Fausto N . Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor. Hepatology. 1993; 18(6):1422-31. View